Current approaches of cough treatment, as the leading symptom of respiratory pathology
Journal Title: Туберкульоз, легеневі хвороби, ВІЛ-інфекція - Year 2019, Vol 0, Issue 3
Abstract
Objective — to assessment of the situation regarding the treatment of cough symptom in common diseases of the bronchopulmonary system in accordance with new guidelines and clinical guidelines. Materials and methods. Test access to a variety of abstract databases was used. Results and discussion. A leading and clinically significant symptom in the frequency of referral to a respiratory system remains cough is the cause of referrals to a family physician by 34 % of adult patients and 20 % of visits by patients of all ages. Today there are more than 50 different causes of cough. In adults, it is more often productive cough, accompanied by sputum, and in many patients it is chronic, as a symptom of the underlying disease. The most widely represented in the pharmaceutical market is a group of expectorants — expectorants and mucolytics. Proper selection of cough suppressants is the key to reducing complications and successful compliance without reducing quality of life. Respix® spray is the only one in Ukraine 5 % solution of ambroxol in the form of a dosage spray with mucolytic and analgesic effects. It is the European standards for the treatment of the respiratory tract and the optimal choice of the drug for the treatment of cough, reducing the disease and reducing the risk of complications, especially for acute viral respiratory infections/flu. Conclusions. Optimization of treatment standards by improving monotherapy (the systemic effects of a single drug for the simultaneous correction of a range of impaired pathophysiological functions) is a major priority of respiratory medicine. Successful choice of drug for the treatment of cough symptom is the key to successful compliance.
Authors and Affiliations
L. D. Todoriko, V. I. Petrenko, I. O. Semianiv, O. S. Shevchenko, V. V. Yakimets
Keywords
Related Articles
- EP ID EP674925
- DOI 10.30978/TB2019-3-52
- Views 104
- Downloads 0
Dysfunction of the liver in patients with newly diagnosed pulmonary tuberculosis, depending on the presence of concomitant viral hepatitis
Objective — the aim of the work is to analyze the liver function in patients with first diagnosed tuberculosis (FDTB) of the lungs before the beginning of antimycobacterial therapy (AMBT) using ultrasound (ultrasound) of...
Extrapulmonary tuberculosis and miliary tuberculosis in patients with TB/HIV co-infection
Abstract
Peculiarity diagnosis of tuberculosis in HIV-infected
Objective — to analyze the spectrum and frequency of detection extrapulmonary clinical forms of tuberculosis and determinate plans of diagnosis among patients with HIV infection. Materials and methods. 55 cases of tube...
Pathologic features of changes of digestive organs and nephros with isolated DRTB and co-infection DRTB/HIV/AIDS
Objective — based on а retrospective analysis to examine the features of pathological changes of the digestive system and nephros to improve clinical diagnosis of pathological conditions of these organs. Materials and...
Condition of the proteolytic system in patients with tuberculous pleurisy
Recently, extrapulmonary forms of tuberculosis are increasingly common, which are not related to the pulmonary system. The largest proportion of extrapulmonary forms is pleural tuberculosis. This disease in case of delay...